Human Genome Epidemiology Literature Finder
|
Records 1 - 11 (of 11 Records) |
| Query Trace: Neoplasms and RIPK1[original query] |
|---|
| Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Nov 17 (11): 3161-9. Cerhan James R, Liu-Mares Wen, Fredericksen Zachary S, Novak Anne J, Cunningham Julie M, Kay Neil E, Dogan Ahmet, Liebow Mark, Wang Alice H, Call Timothy G, Habermann Thomas M, Ansell Stephen M, Slager Susan |
| Prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) 8473T>C polymorphism associated with prognosis for patients with colorectal cancer treated with capecitabine and oxaliplatin. Cancer chemotherapy and pharmacology 2009 Oct 64 (5): 953-60. Kim Jong Gwang, Chae Yee Soo, Sohn Sang Kyun, Moon Joon Ho, Ryoo Hun Mo, Bae Sung Hwa, Kum Yoonseop, Jeon Seong Woo, Lim Kyoung-Hoon, Kang Byung-Mo, Park In-Ja, Choi Gyu Seog, Jun Soo-H |
| RIPK1 and CASP7 polymorphism as prognostic markers for survival in patients with colorectal cancer after complete resection. Journal of cancer research and clinical oncology 2011 Apr 137 (4): 705-13. Chae Yee Soo, Kim Jong Gwang, Sohn Sang Kyun, Lee Su Jeong, Kang Byung Woog, Moon Joon Ho, Park Jae Yong, Jeon Seong Woo, Bae Han-Ik, Choi Gyu Seog, Jun Soo-H |
| Association between CASP7 and CASP14 genetic polymorphisms and the risk of childhood leukemia. Human immunology 2012 Jul 73 (7): 736-9. Park Chulbum, Han Sohee, Lee Kyoung-Mu, Choi Ji-Yeob, Song Nan, Jeon Sujee, Park Sue K, Ahn Hyo Seop, Shin Hee Young, Kang Hyoung Jin, Koo Hong Hoe, Seo Jong Jin, Choi Ji Eun, Kang Daeh |
| Interaction of polymorphisms in mitotic regulator genes with cigarette smoking and pancreatic cancer risk. Molecular carcinogenesis 2013 Nov 52 Suppl 1 E103-9. Jang Ji-Hyun, Cotterchio Michelle, Borgida Ayelet, Liu Geoffrey, Gallinger Steven, Cleary Sean |
| BRAF and AXL oncogenes drive RIPK3 expression loss in cancer. PLoS biology 2018 8 16 (8): e2005756. Najafov Ayaz, Zervantonakis Ioannis K, Mookhtiar Adnan K, Greninger Patricia, March Ryan J, Egan Regina K, Luu Hoang Son, Stover Daniel G, Matulonis Ursula A, Benes Cyril H, Yuan Junyi |
| Targeting RIPK1 in AML cells carrying FLT3-ITD. International journal of cancer 2019 3 145 (6): 1558-1569. Hillert Laura K, Bettermann-Bethge Kira, Nimmagadda Subbaiah Chary, Fischer Thomas, Naumann Michael, Lavrik Inna |
| Single-nucleotide polymorphism rs17548629 in RIPK1 gene may be associated with lung cancer in a young and middle-aged Han Chinese population. Cancer cell international 2020 20 143. Yang Shimin, Yu Fanglin, Lin Mingyan, Sun Linyi, Wei Junjie, Lai Cheng, Cai Lin, Hu Zhijian, He F |
| RIPK1 polymorphisms alter the susceptibility to cervical Cancer among the Uyghur population in China. BMC cancer 2020 Apr 20 (1): 299. Tuoheti Zulipiyamu, Han Lili, Husaiyin Sulaiya, Liu Xiaoxi, Ma Chunhua, Niyazi Mayinu |
| RIPK1 polymorphisms and expression levels: impact on genetic susceptibility and clinical outcome of epithelial ovarian cancer. Cancer cell international 2023 11 23 (1): 290. Xuedong Wang, Kui Deng, Jing Tao, Juan Zou, Yiting Du, Li D |
| Genomic and Socioeconomic Determinants of Racial Disparities in Breast Cancer Survival: Insights from the All of Us Program. Cancers 2024 10 16 (19): . Nubaira Rizvi, Hui Lyu, Leah Vaidya, Xiao-Cheng Wu, Lucio Miele, Qingzhao |
- Page last reviewed:Feb 1, 2024
- Content source: